DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors
- 30 June 1989
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 33 (3) , 360-367
- https://doi.org/10.1016/0090-8258(89)90528-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pitfalls in the preparation of nuclear suspensions from paraffin‐embedded tissue for flow cytometryCytometry, 1986
- Das ovarielle Deckepithel und seine histogenetische Beziehung zum OvarialkarzinomGeburtshilfe und Frauenheilkunde, 1986
- DNA Flow Cytometry of Ovarian Tumors with Correlation to HistopathologyInternational Journal of Gynecological Pathology, 1985
- Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometryCytometry, 1984
- DNS-Messung von malignen Tumoren mittels Impulszytophotometrie: Prinzipien und Bedeutung für die Beurteilung von Wachstumsverhalten und AbnormitätsgradDeutsche Medizinische Wochenschrift (1946), 1984
- Estrogen and progesterone receptors in ovarian neoplasmsGynecologic Oncology, 1983
- Ovarian Epithelial Tumors of Low Malignant Potential: A ReviewInternational Journal of Gynecological Pathology, 1983
- Choice of postoperative therapy based on prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Disagreement of histopathological diagnoses of different pathologists in ovarian tumors — with some theoretical considerationsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1982
- Psammoma bodies in serous carcinoma of the ovaryAmerican Journal of Obstetrics and Gynecology, 1971